Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tetsuya Okayama is active.

Publication


Featured researches published by Tetsuya Okayama.


International Journal of Hyperthermia | 2009

Effect of hyperthermia combined with gemcitabine on apoptotic cell death in cultured human pancreatic cancer cell lines

Satoko Adachi; Satoshi Kokura; Tetsuya Okayama; Takeshi Ishikawa; Tomohisa Takagi; Osamu Handa; Yuji Naito; Toshikazu Yoshikawa

Background and aim: It is reported that NF-κB is activated by chemotherapy in some cancer cell lines and NF-κB activation is one of the mechanisms by which tumors are induced to become resistant to chemotherapy. We reported that heat-treatment-induced heat shock protein 70 (Hsp70) could inhibit I-kappa-B kinase, resulting in the inhibition of NF-κB activation. Therefore, we speculated that activated NF-κB in a pancreatic cell line might be inhibited by heat treatment, resulting in the enhancement of gemcitabine-induced cytotoxicity. Methods: We used the human pancreatic carcinoma cell lines AsPC-1 and MIAPaCa-2. Both cell lines were treated with various concentrations (0, 5, 10, 20, and 30 μM) of gemcitabine for 24 h. Heat treatment (43°C, 1 h) was performed at various times relative to gemcitabine treatment. The effect of gemcitabine and heat treatment on cell survival was determined by WST-8 assay. The status of NF-κB in carcinoma cells exposed to gemcitabine was investigated by electrophoretic mobility shift assay and immunocytochemistry. We analyzed apoptosis and necrosis in AsPC-1 and MIAPaCa-2 cells by flow cytometry. Furthermore, the levels of Hsp70, cyclin D1, caspase-3, and vascular endothelial growth factor in each treatment group were detected by western blotting. Results: (1) Significant cytotoxicity was observed with gemcitabine. (2) Gemcitabine activated NF-κB binding activity in both cell lines. (3) Heat treatment inhibited the gemcitabine-induced activation of NF-κB. (4) Heat treatment enhanced the cytotoxicity of gemcitabine, especially when heat treatment was performed 24 h before gemcitabine was given. (5) The levels of Hsp70 were increased by heat treatment. Gemcitabine did not affect the protein level of Hsp70. The levels of pro-caspase-3 were decreased by heat treatment combined with gemcitabine. Conclusions: Heat treatment inhibited gemcitabine-induced activation of NF-κB, resulting in the enhancement of the cytotoxicity of gemcitabine.


Digestive Endoscopy | 2014

Ability of a novel blue laser imaging system for the diagnosis of colorectal polyps.

Naohisa Yoshida; Nobuaki Yagi; Yutaka Inada; Munehiro Kugai; Tetsuya Okayama; Kazuhiro Kamada; Kazuhiro Katada; Kazuhiko Uchiyama; Takeshi Ishikawa; Osamu Handa; Tomohisa Takagi; Hideyuki Konishi; Satoshi Kokura; Akio Yanagisawa; Yuji Naito

A new endoscope system with a laser light source, blue laser imaging (BLI), has been developed by Fujifilm that allows for narrow‐band light observation. The aim of the present study was to evaluate the utility of BLI for the diagnosis of colorectal polyps.


Journal of Gastroenterology and Hepatology | 2008

Increased intestinal expression of heme oxygenase-1 and its localization in patients with ulcerative colitis.

Tomohisa Takagi; Yuji Naito; Katsura Mizushima; Yayoi Nukigi; Hitomi Okada; Takahiro Suzuki; Ikuhiro Hirata; Tatsushi Omatsu; Tetsuya Okayama; Osamu Handa; Satoshi Kokura; Hiroshi Ichikawa; Toshikazu Yoshikawa

Background:  Heme oxygenase‐1 (HO‐1) is regarded as a sensitive and reliable indicator of cellular oxidative stress. Two end products of heme degradation, carbon monoxide (CO) and bilirubin, are involved in the protective role of HO‐1 against oxidative injury. We have demonstrated enhanced expression of this enzyme and increased concentration of CO in experimental models of colitis, but the role of HO‐1 in patients with ulcerative colitis (UC) has not been extensively investigated. The aim of the present study was to determine the intestinal levels and localization of ho‐1 mRNA and HO‐1 protein in patients with UC.


Journal of Gastroenterology | 2009

Involvement of reactive oxygen species in indomethacin-induced apoptosis of small intestinal epithelial cells

Tatsushi Omatsu; Yuji Naito; Osamu Handa; Natsuko Hayashi; Katsura Mizushima; Ying Qin; Ikuhiro Hirata; Satoko Adachi; Tetsuya Okayama; Etsuko Kishimoto; Tomohisa Takagi; Satoshi Kokura; Hiroshi Ichikawa; Toshikazu Yoshikawa

BackgroundThe precise pathogenic mechanism of nonsteroidal antiinflammatory drug-induced small intestinal injury is still unknown. In the present study, we investigated the mechanism by which indomethacin induced mucosal injury by using an in vitro model of small intestine.MethodsThe colon cancer cell line Caco-2, exhibiting a small intestinal phenotype starting as a crypt cell and differentiating to a villous phenotype, and RIE, a rat intestinal epithelial cell line, were employed. Indomethacin was added to differentiated the Caco-2 and RIE monolayer, and cell death was quantified by MTT assay and LDH release in the cell culture supernatant. Indomethacin-induced cell death was also qualified by fluorescent probes under the fluorescent microscope. As a functional study, the permeability of the Caco-2 monolayer was assessed by measuring transepithelial electrical resistance (TEER) and the flux of FITC-conjugated dextran across the monolayer. Indomethacin-induced reactive oxygen species production in Caco-2 and RIE was evaluated by redoxsensitive fluorogenic probes using a fluorometer. In some experiments, antioxidants were used to clarify the role of reactive oxygen species on indomethacin-induced Caco-2 cell death.ResultsIndomethacin caused cell death (mainly apoptosis) of Caco-2 and RIE in a dose-and time-dependent manner that was correlated with increased permeability of the Caco-2 monolayer. Exposure of Caco-2 and RIE with indomethacin also resulted in a significant reactive oxygen species production that was inhibited by the pretreatment of these cells with antioxidants.ConclusionsTaken together, reactive oxygen species production is one of the mechanisms by which indomethacin induced small intestinal injury.


Digestion | 2009

Heat-Shock Protein 70-Overexpressing Gastric Epithelial Cells Are Resistant to Indomethacin-Induced Apoptosis

Ikuhiro Hirata; Yuji Naito; Osamu Handa; Natsuko Hayashi; Katsura Mizushima; Satoko Adachi; Tatsushi Omatsu; Tetsuya Okayama; Etsuko Kishimoto; Hiroshi Ichikawa; Tomohisa Takagi; Satoshi Kokura; Michiro Otaka; Toshikazu Yoshikawa

Background/Aims: Protecting intestinal mucosa from nonsteroidal anti-inflammatory drugs is still an unsolved problem. It has been revealed that apoptosis in epithelial cells as a result of mitochondrial injury is an important pathogenesis in indomethacin-induced gastric mucosal injury. In this study, we revealed the effect of overexpressed heat-shock protein 70 (HSP70) in indomethacin-induced apoptosis and oxidative stress. Methods: HSP70-overexpressing rat gastric mucosal cells (7018-RGM-1 cells) and control cells (pBK-CMV-12 cells) were used and treated with 0–500 μM of indomethacin for 24 h. Cell viability and cytotoxity were measured by a WST-8 assay and a lactate dehydrogenase release assay, respectively. Apoptosis was observed by fluorescence microscopy staining with Hoechst 33342 and propidium iodide. The expression of Bcl-2 family proteins, activation of caspase-3, and 4-hydroxy-2-nonenal (4-HNE)-modified proteins were assessed by Western blot analysis. Results: Indomethacin caused apoptosis of gastric epithelial cells. The 7018-RGM-1 cells survived significantly after indomethacin treatment compared to the control cells. The increase in pro-apoptotic Bad proteins, the decrease in anti-apoptotic Bcl-2 proteins, and caspase activation were all suppressed in the 7018-RGM-1 cells. A lower level of indomethacin-induced 4-HNE-modification was detected in the 7018-RGM-1 cells than in the control cells. Conclusion: Overexpressed HSP70 may potentiate resistance to apoptosis and oxidative stress in indomethacin-induced gastric epithelial cell injury.


Endoscopy International Open | 2016

Linked color imaging improves endoscopic diagnosis of active Helicobacter pylori infection.

Osamu Dohi; Nobuaki Yagi; Yuriko Onozawa; Reiko Kimura-Tsuchiya; Atsushi Majima; Tomoko Kitaichi; Yusuke Horii; Kentaro Suzuki; Akira Tomie; Tetsuya Okayama; Naohisa Yoshida; Kazuhiro Kamada; Kazuhiro Katada; Kazuhiko Uchiyama; Takeshi Ishikawa; Tomohisa Takagi; Osamu Handa; Hideyuki Konishi; Yuji Naito; Yoshito Itoh

Background and study aims: Linked color imaging (LCI) is a new image-enhanced endoscopy technique using a laser light source to enhance slight differences in mucosal color. The aim of this study was to compare the usefulness of LCI and conventional white light imaging (WLI) endoscopy for diagnosing Helicobacter pylori (H. pylori). Patients and methods: We retrospectively analyzed images from 60 patients examined with WLI and LCI endoscopy between October 2013 and May 2014. Thirty patients had H. pylori infections, and other thirty patients tested negative for H. pylori after eradication therapy. Four endoscopists evaluated the 2 types of images to determine which was better at facilitating a diagnosis of H. pylori infection. Results: H. pylori infection was identified with LCI by enhancing the red appearance of the fundic gland mucosa. The accuracy, sensitivity, and specificity for diagnosing H. pylori infection using WLI were 74.2 %, 81.7 %, and 66.7 %, respectively, while those for LCI were 85.8 %, 93.3 %, and 78.3 %, respectively. Thus, the accuracy and sensitivity for LCI were significantly higher than those for WLI (P = 0.002 and P = 0.011, respectively). The kappa values for the inter- and intraobserver variability among the 4 endoscopists were higher for LCI than for WLI. Conclusions: H. pylori infection can be identified by enhancing endoscopic images of the diffuse redness of the fundic gland using LCI. LCI is a novel image-enhanced endoscopy and is more useful for diagnosing H. pylori infection than is WLI.


International Journal of Cancer | 2015

Tumor inoculation site affects the development of cancer cachexia and muscle wasting

Tatsuzo Matsuyama; Takeshi Ishikawa; Tetsuya Okayama; Kaname Oka; Satoko Adachi; Katsura Mizushima; Reiko Kimura; Manabu Okajima; Hiromi Sakai; Naoyuki Sakamoto; Kazuhiro Katada; Kazuhiro Kamada; Kazuhiko Uchiyama; Osamu Handa; Tomohisa Takagi; Satoshi Kokura; Yuji Naito; Yoshito Itoh

The phenotype and severity of cancer cachexia differ among tumor types and metastatic site in individual patients. In this study, we evaluated if differences in tumor microenvironment would affect the development of cancer cachexia in a murine model, and demonstrated that body weight, adipose tissue and gastrocnemius muscle decreased in tumor‐bearing mice. Interestingly, a reduction in heart weight was observed in the intraperitoneal tumor group but not in the subcutaneous group. We evaluated 23 circulating cytokines and members of the TGF‐β family, and found that levels of IL‐6, TNF‐α and activin A increased in both groups of tumor‐bearing mice. Eotaxin and G‐CSF levels in the intraperitoneal tumor group were higher than in the subcutaneous group. Atrogin 1 and MuRF1 mRNA expressions in the gastrocnemius muscle increased significantly in both groups of tumor‐bearing mice, however, in the myocardium, expression of these mRNAs increased in the intraperitoneal group but not in subcutaneous group. Based on these results, we believe that differences in microenvironment where tumor cells develop can affect the progression and phenotype of cancer cachexia through alterations in various circulating factors derived from the tumor microenvironment.


Endoscopy | 2014

L-menthol improves adenoma detection rate during colonoscopy: a randomized trial.

Ken Inoue; Osamu Dohi; Yasuyuki Gen; Masayasu Jo; Takeshi Mazaki; Kazuhiko Tokita; Naohisa Yoshida; Tetsuya Okayama; Kazuhiro Kamada; Kazuhiro Katada; Kazuhiko Uchiyama; Takeshi Ishikawa; Osamu Handa; Tomohisa Takagi; Hideyuki Konishi; Naoki Wakabayashi; Nobuaki Yagi; Yuji Naito; Yoshito Itoh

BACKGROUND AND STUDY AIMS Colonoscopy is one of the most reliable methods for the detection of colorectal neoplasms. However, colonic peristalsis during colonoscopy results in some neoplastic lesions being hidden from view and commonly requires an intravenous or intramuscular injection of antispasmodic agents, which may sometimes causes unexpected adverse reactions. The aim of this study was to evaluate the efficacy of L-menthol spray as an antiperistaltic agent and its effect on adenoma detection. PATIENTS AND METHODS This was a prospective, randomized, single-blind placebo-controlled trial. A total of 226 patients who were scheduled to undergo colonoscopy were randomly assigned to receive either 20 mL of 1.6 % L-menthol (n = 118) or placebo (n = 108). Both treatments were sprayed locally onto the colonic mucosa via an endoscope. The adenoma detection rate (ADR) and the proportion of patients with no peristalsis were the primary and secondary outcomes, respectively. RESULTS The ADR was significantly higher in the L-menthol group than in the placebo group (60.2 % vs. 42.6 %; P = 0.0083). The proportion of patients with no peristalsis after treatment with L-menthol was significantly higher than in the placebo group (71.2 % vs. 30.9 %; P < 0.0001). There were no adverse effects in either group. CONCLUSIONS The results suggest that the suppression of colonic peristalsis by L-menthol sprayed directly onto the colonic mucosa improves the ADR. CLINICAL TRIAL REGISTRATION ID: UMIN 000007972.


International Journal of Hyperthermia | 2007

Antitumor effect of whole body hyperthermia with α-galactosylceramide in a subcutaneous tumor model of colon cancer

Takeshi Hattori; Satoshi Kokura; Toshimitsu Okuda; Tetsuya Okayama; Tomohisa Takagi; Osamu Handa; Yuji Naito; Norimasa Yoshida; Toshikazu Yoshikawa

Aim: Whole body hyperthermia (WBH) has been used clinically as an adjunct to radio- and chemotherapy in patients with various cancers. Recently, it has been reported that an activation of the immune system has recently been reported as a possible contributor to the therapeutic effects of WBH. Conversely, the glycolipid α-galactosylceramide (α-GalCer) is recognized by natural killer (NK) T cells together with the monomorphic MHC-like antigen, CD1d, in mice and humans. This study investigated the antitumor effects of WBH combined with α-GalCer in a mouse subcutaneous tumor model of colon cancer. Methods: Colon26 cells were inoculated subcutaneously into male BALB/c mice to establish subcutaneous tumor. Colon26-bearing mice were treated with WBH using far infrared rays three times/week. Rectal temperature was maintained for 60 min at 41°C. In some experimental groups, α-GalCer was intraperitoneally injected before WBH. We investigated the therapeutic effects of WBH, α-GalCer and combined therapy. Results: (1) Compared with controls, WBH alone resulted in significant inhibition of tumor growth. (2) No inhibitory effect on tumor growth was seen with α-GalCer. (3) The combination of WBH and α-GalCer showed significant inhibition of tumor growth and prolongation of survival. (4) Serum IFN-γ increased after 3 h and returned to basal levels by 24 h after α-GalCer administration. (5) CTL activity was enhanced following combination therapy with WBH and α-GalCer. Conclusion: WBH showed antitumor effects in a mouse subcutaneous tumor model of colon cancer. Addition of α-GalCer increased the efficacy of WBH, probably via enhancement of immune response.


Journal of Clinical Biochemistry and Nutrition | 2018

The influence of long-term use of proton pump inhibitors on the gut microbiota: an age-sex-matched case-control study

Tomohisa Takagi; Yuji Naito; Ryo Inoue; Saori Kashiwagi; Kazuhiko Uchiyama; Katsura Mizushima; Saeko Tsuchiya; Tetsuya Okayama; Osamu Dohi; Naohisa Yoshida; Kazuhiro Kamada; Takeshi Ishikawa; Osamu Handa; Hideyuki Konishi; Kayo Okuda; Yoshimasa Tsujimoto; Hiromu Ohnogi; Yoshito Itoh

Proton pump inhibitors (PPIs) are widely used to treat gastro-esophageal reflux and prevent gastric ulcers, and have been considered as low risk. However, recent studies have identified possible associations between PPI use and gut microbiota, suggesting that PPIs use increases the risk of enteric infections, including Clostridium difficile infection. To investigate gut microbiota in Japanese PPIs users, we conducted 16S metagenomics analysis of fecal samples collected from PPI users and healthy adults. In total, 36 PPI users and 36 PPI non-users (as control subjects) matched by age and sex were recruited and fecal samples were obtained to analyze the gut microbiome using 16S rRNA gene sequencing. There were significant differences in the microbial structure between PPI non-users and PPI users. In contrast, the analysis of α-diversity revealed no significant differences between PPI non-users and PPI users. When comparing in genus level between these two groups, the genera Streptococcus was significantly abundant and the genera Faecalibacterium was significantly decreased in PPI users. Our findings indicate a probable association between PPI use and the alternation of microbiota. These alterations might provide a mechanism by which PPIs predispose enteric infection such as Clostridium difficile infection.

Collaboration


Dive into the Tetsuya Okayama's collaboration.

Top Co-Authors

Avatar

Yuji Naito

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Osamu Handa

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Tomohisa Takagi

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Takeshi Ishikawa

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Kazuhiko Uchiyama

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Yoshito Itoh

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Kazuhiro Kamada

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Hideyuki Konishi

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Naohisa Yoshida

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Kazuhiro Katada

Kyoto Prefectural University of Medicine

View shared research outputs
Researchain Logo
Decentralizing Knowledge